News Center

Fresh Snow Heralds a New Journey, Joint Efforts Draw Grand Blueprint | Henan Liyuan Group Visits Jingke Biotechnology to Accelerate Full-industry-chain Cooperation on Core Pharmaceutical Intermediates

Date: 20 January 2026
Source: Official WeChat Account of Anhui Jingke Biotechnology Co., Ltd.
Link: https://mp.weixin.qq.com/s/kN7NE-e6LMvFS7DnUCv4yA

Auspicious snow falls at year-end to kick off a new chapter of cooperation. On January 19, winter snow adorned Hefei with distinctive scenery and set a warm prelude to in-depth cooperation between Anhui Jingke Biotechnology Co., Ltd. (hereinafter referred to as Jingke Biotechnology) and Henan Liyuan Group.

On the afternoon of January 19, Mr. Fu and Dr. Cao from Henan Liyuan Group paid a dedicated visit to Jingke Biotechnology’s Hefei R&D Center for site inspection and seminar exchanges. Xu Hai, Chairman, and Gao Jianwei, General Manager of Jingke Biotechnology, extended a warm welcome on behalf of the company and accompanied the delegation throughout the visit.

Led by the reception team, Mr. Fu and Dr. Cao first toured core zones of the Hefei R&D Center to gain in-depth insights into Jingke’s R&D strengths, technical layout and upgraded product achievements, speaking highly of the company’s R&D competence in synthetic biology.

During the subsequent forum, both parties focused discussions on deepened cooperation over core products: D-p-hydroxyphenylglycine series. Drawing on respective resource edges and industrial experience, participants held open discussions on key matters including product R&D upgrading, market expansion and coordinated supply chain management. They shared insights on industrial trends and finalized core directions and implementation routes for follow-up cooperation.

Mr. Fu stated that the on-site visit enabled him to form a more intuitive and thorough understanding of Jingke’s R&D proficiency and sincere willingness for collaboration. He pointed out that D-p-hydroxyphenylglycine series boasts promising market prospects and enormous cooperation potential. Taking this seminar as a turning point, both sides expect to deepen partnership and deliver win-win outcomes at an early date.

The dialogue boosted mutual trust and consensus while accelerating the execution of pending collaborative projects. On January 20, the delegation from Liyuan Group proceeded to Tongling Jingke, Jingke’s manufacturing base, to inspect on-site production management, quality control and large-scale production capacity, further consolidating confidence for bilateral cooperation.


Auspicious snow promises a bumper year, making it the prime time for collaboration. From brainstorming at the R&D center to capability verification at the production base, the partnership between Jingke Biotechnology and Henan Liyuan Group is steadily turning blueprints into tangible reality. Leveraging complementary strengths and firm determination from both sides, the two enterprises are poised to break new ground in the industrialization of synthetic biology and embrace a prosperous shared future hand in hand!